ClinicalTrials.Veeva

Menu

Topic Compatibility Dermacyd Wipes - Lactoserum - Hygiene

Sanofi logo

Sanofi

Status and phase

Completed
Phase 3

Conditions

Hygiene

Treatments

Drug: lactoserum

Study type

Interventional

Funder types

Industry

Identifiers

NCT00371852
LACTO_L_01811

Details and patient eligibility

About

The purpose of this study is to demonstrate the absence of irritation potential (primary dermic irritability and cumulated dermic irritability) and allergy (sensibilization) of the product Dermacyd wipes.

Sex

All

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Phototypes: I, II, III and IV;
  • Integral skin test in the region;

Exclusion criteria

  • Lactation or gestation
  • Use of Anti-inflammatory and/or immune-suppression drugs
  • Personnel history of atopy;
  • History of sensibilization or irritation for topic products;
  • Active cutaneous disease;
  • Use of new drugs and/or cosmetics during the study

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems